â– LECTURE OVERVIEW: Tricyclic Antidepressant (TCA) overdose is a major toxicological emergency characterized by multi-system receptors blockade.
â– THE CARDIOVASCULAR AND CENTRAL TOXICITIES:
1. Rapid Cardiac Sodium Channel Inactivation: TCAs block fast sodium channels (IKr) in myocardial tissue, slowing Phase 0 of the action potential and prolonging the QRS interval. This drives severe intraventricular conduction delays and lethal ventricular arrhythmias.
2. Anticholinergic Overdrive: Blocks muscarinic (M1) receptors, producing central and peripheral anticholinergic syndrome (altered mental status, dry skin, dilated non-reactive pupils, urinary retention, and hyperthermia).
3. Vascular Collapse: Inhibits alpha-1 adrenergic receptors, preventing peripheral vasoconstriction and causing refractory hypotension.
4. Neuronal Excitability: Blocks GABA-A receptors in the brain, lowering the seizure threshold and precipitating status epilepticus.
â– MICROSCOPIC PATHOBIOLOGY:
Histopathologic biopsy reveals cellular atypia, pleomorphism, lipid vacuolar engorgement, or characteristic structural inclusions (e.g., specific nuclear changes, cytoplasmic inclusions) which are diagnostic for the pathology.
â– EPIDEMIOLOGICAL PROFILE & DENSITY CORRELATIONS:
Global burden patterns reveal notable associations with lifestyle habits, regional environmental factors, and inherited traits.
[HY-BOARD-1346]
🌟 Dynamic Clinical Key:
First-line, life-saving treatment is intravenous Sodium Bicarbonate (NaHCO3). The sodium load increases extracellular sodium concentration to overcome the TCA-mediated blockade, while the systemic alkalorization (raising pH to 7.45-7.55) converts the TCA molecule into its neutral, non-ionized form, reducing its affinity for sodium channels. Confirm histologic findings with immunophenotypic cell markers using flow cytometry. Focus screening efforts on high-risk geographic regions to maximize clinical yield.